Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...

The White House recently announced a landmark deal with pharmaceutical companies Eli Lilly and Nordisk that will impact ...

When Susan Akin first started injecting a coveted weight-loss drug early this year, the chaos in her brain quieted. The ...

The trillion-dollar club has become crowded with mostly tech names riding the AI boom. Eli Lilly might soon join them for a ...

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

Explore Zepbound's "Changing the Threads" exhibit, which is redefining the stigma of obesity through powerful stories and ...

Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after taking tirzepatide (Zepbound), showing the medication suppressed brain ...

"Developing new ways to treat these patients is of the utmost importance," Dr. Casey H. Halpern, a senior author of the study ...

Novo Nordisk announced Monday that it is significantly cutting the prices of its blockbuster GLP-1 drugs, Wegovy (for weight ...

Originally developed for diabetes, GLP-1 drugs like Ozempic are showing remarkable potential in combating addiction. Emerging ...